Citation Impact
Citing Papers
A TAZ–ANGPTL4–NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer
2019
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity
2018 Science
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Ferroptosis regulation by the NGLY1/NFE2L1 pathway
2022 StandoutNobel
Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
2023 StandoutNobel
Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer
2021
Systems modeling accurately predicts responses to genotoxic agents and their synergism with BCL-2 inhibitors in triple negative breast cancer cells
2018
Breast cancer
2019 Standout
Estrogen receptor mutations and their role in breast cancer progression
2014
A Genome-wide Haploid Genetic Screen Identifies Regulators of Glutathione Abundance and Ferroptosis Sensitivity
2019
Inference and analysis of cell-cell communication using CellChat
2021 Standout
scAI: an unsupervised approach for the integrative analysis of parallel single-cell transcriptomic and epigenomic profiles
2020
Ferroptosis: molecular mechanisms and health implications
2020 Standout
A network modeling approach to elucidate drug resistance mechanisms and predict combinatorial drug treatments in breast cancer
2017
Membrane Initiated Estrogen Signaling in Breast Cancer1
2006
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer
2019
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
A view on drug resistance in cancer
2019 StandoutNature
Breast cancer
2016 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Nrf2-Keap1 signaling in oxidative and reductive stress
2018 Standout
DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway
2021
MESH1 is a cytosolic NADPH phosphatase that regulates ferroptosis
2020
A Protocol for the Comprehensive Flow Cytometric Analysis of Immune Cells in Normal and Inflamed Murine Non-Lymphoid Tissues
2016
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
2017 StandoutNobel
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Subfertility, Uterine Hypoplasia, and Partial Progesterone Resistance in Mice Lacking the Krüppel-like Factor 9/Basic Transcription Element-binding Protein-1 (Bteb1) Gene
2004
Endometriosis
2009 Standout
NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism
2020
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis
2019
The obese adipose tissue microenvironment in cancer development and progression
2018
Androgen insensitivity syndrome
2015
Neutrophil metabolism in the cancer context
2021
Potential Drug Interactions and Duplicate Prescriptions Among Cancer Patients
2007
Impact of biosolids and wastewater effluent application to agricultural land on corticosterone content in lettuce plants
2015
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Therapeutic strategies to target RAS-mutant cancers
2018
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Targeting apoptosis in cancer therapy
2020 Standout
DAXX, FLASH, and FAF-1 Modulate Mineralocorticoid and Glucocorticoid Receptor-Mediated Transcription in Hippocampal Cells—Toward a Basis for the Opposite Actions Elicited by Two Nuclear Receptors?
2004
Roadmap to embryo implantation: clues from mouse models
2006 Standout
Stress and the brain: from adaptation to disease
2005 Standout
Indian Hedgehog and Its Targets in Human Endometrium: Menstrual Cycle Expression and Response to CDB-2914
2010
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma
2019
Emerging Biological Principles of Metastasis
2017 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Oxidative Stress in Cancer
2020 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Pyroptosis: A new frontier in cancer
2019 Standout
Male breast cancer: a disease distinct from female breast cancer
2018
Occurrence and fate of emerging contaminants in municipal wastewater treatment plants from different geographical regions-a review
2017 Standout
Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer
2014
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Mitochondrial TCA cycle metabolites control physiology and disease
2020 Standout
Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivity
2018
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism
2019
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Potential significance of physiological and pharmacological glucocorticoids in early pregnancy
2008
Estrogen rapid action via protein complex formation involving ERα and Src
2005
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Mechanisms of implantation: strategies for successful pregnancy
2012 Standout
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
2014
Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer
2015
Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST Study
2015
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis
2020
Breast Cancer Treatment
2019 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis
2005
Gefitinib Reverses Chemotherapy Resistance in Gefitinib-Insensitive Multidrug Resistant Cancer Cells Expressing ATP-Binding Cassette Family Protein
2005
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer
2016
Combination therapy in combating cancer
2017 Standout
Obesity, Inflammation, and Cancer
2016
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
Selective androgen receptor modulators in preclinical and clinical development
2008
Obesity and the tumor microenvironment
2017 Science
Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer
2018
Works of Suzanne E. Wardell being referenced
27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
2013 Science
Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast Cancer
2015
Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling
2016
A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product
2017
The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells
2017
Mechanisms Controlling Agonist and Antagonist Potential of Selective Progesterone Receptor Modulators (SPRMs)
2005
Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer
2017
The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy
2011
International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors
2006
Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways
2002
Partial Agonist Activity of the Progesterone Receptor Antagonist RU486 Mediated by an Amino-Terminal Domain Coactivator and Phosphorylation of Serine400
2009
Systematic identification of signaling pathways with potential to confer anticancer drug resistance
2014
Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer
2015
Jun Dimerization Protein 2 Functions as a Progesterone Receptor N-Terminal Domain Coactivator
2002
PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation
2016
Gefitinib, a novel, orally administered agent for the treatment of cancer
2004